iSiP, Inc.

Re-Design Drug Discovery Process

About Us

Our mission is to create an overwhelmingly efficient system that combines AI and physical simulation for truly scientific use, to advance the pipeline and create new drugs.

Mission

Realize a three-way business with research as a source of competitiveness

Purchaser

Bringing better treatments to patients through new drug

Seller

Create a domestic research base and create sustainable jobs for diverse talent

Society

Make the pharmaceutical industry a major export industry by 2035 through the out-licensing of a pipeline of new drugs

News

2024

2024/8/19: Innovative AI Drug Discovery Engine Achieves High-Precision Activity Prediction, Verified by Cell-Based Assays - Accurately predicts activity for a wide range of compounds,including activity cliffs, without the need for reference compounds -

2024/4/26: New Technology Developed to Generate Novel Hit Compounds Solely from Fuzzily Protein 3D Structures - Successful High-Efficiency Discovery of Novel Scaffolds for Orphan GPCR "GPR17" -

2023

2023/10/03: Notice of Verification of the Technology for Creating Hit Compounds that Unnecessary of the Three-Dimensional Structure of Complexes

2023/08/22: Notice of Financing (Japanese Only)

2023/03/22: Announcement of the Creation of Novel Antagonist Hit Compounds for PAC1 Receptor using AI-driven Peptide Small Molecule Technology

2023/02/02: Notice of Hit Creation in Ion-Channel Targets by Application of AI Peptide Decomposition Technology

For Inquiries about joint research, employment, etc., please contact us here.

(google form)